Home » Stocks » GMAB » Financials

Genmab A/S (GMAB)

Stock Price: $44.05 USD -0.03 (-0.07%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions DKK. Fiscal year is January - December.
Year2020201920182017
Revenue10,1115,3663,0252,365
Revenue Growth88.43%77.39%27.91%-
Gross Profit10,1115,3663,0252,365
Selling, General & Admin661342214147
Research & Development3,1372,3861,431874
Operating Expenses3,7982,7281,6451,021
Operating Income6,3132,6381,3801,344
Interest Expense / Income1,5587.0011.00352
Other Expense / Income-1,149-228-243-72.00
Pretax Income5,9042,8591,6121,064
Income Tax1,146693140-40.00
Net Income4,7582,1661,4721,104
Shares Outstanding (Basic)65.0764.3064.30-
Shares Change1.2%0%--
EPS (Basic)7.303.442.401.81
EPS (Diluted)7.223.402.371.78
EPS Growth112.2%43.4%33.54%-
Free Cash Flow Per Share9.411.890.84-
Gross Margin100%100%100%100%
Operating Margin62.4%49.2%45.6%56.8%
Profit Margin47.1%40.4%48.7%46.7%
FCF Margin60.6%22.6%17.8%63.4%
Effective Tax Rate19.4%24.2%8.7%-
EBITDA7,4622,8661,6231,416
EBITDA Margin73.8%53.4%53.7%59.9%
EBIT7,4622,8661,6231,416
EBIT Margin73.8%53.4%53.7%59.9%